Renaissance Technologies’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$293K Buy
209,501
+151,901
+264% +$213K ﹤0.01% 3047
2025
Q1
$92.7K Sell
57,600
-132,800
-70% -$214K ﹤0.01% 3209
2024
Q4
$240K Buy
190,400
+63,400
+50% +$79.9K ﹤0.01% 3114
2024
Q3
$239K Buy
127,000
+107,800
+561% +$203K ﹤0.01% 3065
2024
Q2
$142K Buy
+19,200
New +$142K ﹤0.01% 3115
2023
Q3
Sell
-48,302
Closed -$358K 3645
2023
Q2
$358K Sell
48,302
-53,898
-53% -$399K ﹤0.01% 3048
2023
Q1
$966K Sell
102,200
-57,400
-36% -$543K ﹤0.01% 2500
2022
Q4
$1.7M Buy
159,600
+81,300
+104% +$866K ﹤0.01% 2179
2022
Q3
$578K Buy
78,300
+20,600
+36% +$152K ﹤0.01% 2845
2022
Q2
$278K Buy
+57,700
New +$278K ﹤0.01% 3500
2020
Q3
Sell
-120,212
Closed -$1.27M 3363
2020
Q2
$1.27M Buy
120,212
+80,664
+204% +$851K ﹤0.01% 2429
2020
Q1
$230K Buy
39,548
+6,537
+20% +$38K ﹤0.01% 3066
2019
Q4
$216K Buy
33,011
+16,325
+98% +$107K ﹤0.01% 3175
2019
Q3
$115K Buy
16,686
+9,632
+137% +$66.4K ﹤0.01% 3249
2019
Q2
$52K Buy
7,054
+2,409
+52% +$17.8K ﹤0.01% 3450
2019
Q1
$67K Buy
4,645
+1,911
+70% +$27.6K ﹤0.01% 3342
2018
Q4
$32K Sell
2,734
-11,385
-81% -$133K ﹤0.01% 3307
2018
Q3
$314K Buy
14,119
+1,202
+9% +$26.7K ﹤0.01% 3003
2018
Q2
$248K Buy
12,917
+11,974
+1,270% +$230K ﹤0.01% 3022
2018
Q1
$10K Buy
+943
New +$10K ﹤0.01% 3336
2017
Q3
Sell
-382
Closed -$14K 3195
2017
Q2
$14K Sell
382
-2,729
-88% -$100K ﹤0.01% 3162
2017
Q1
$141K Sell
3,111
-707
-19% -$32K ﹤0.01% 3040
2016
Q4
$100K Buy
+3,818
New +$100K ﹤0.01% 3102
2015
Q2
Sell
-3,160
Closed -$234K 3214
2015
Q1
$234K Buy
+3,160
New +$234K ﹤0.01% 2833